Annovis Bio (ANVS)
(Delayed Data from NYSE)
$18.01 USD
+4.41 (32.43%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $17.66 -0.35 (-1.94%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.87 | 0.00% |
Earnings Summary
For their last quarter, Annovis Bio (ANVS) reported earnings of -$1.09 per share, beating the Zacks Consensus Estimate of $-1.35 per share. This reflects a positive earnings surprise of 19.26%. Look out for ANVS's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.87 per share, reflecting a year-over-year increase of 26.89%.
Earnings History
Price & Consensus
Zacks News for ANVS
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
ANVS: What are Zacks experts saying now?
Zacks Private Portfolio Services